Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

September 17, 2021
Open Access

A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications.

Scientific Reports
William J BehofWellington Pham
September 17, 2021

Hippocampal connectivity with retrosplenial cortex is linked to neocortical tau accumulation and memory function.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Jacob ZiontzWilliam J Jagust
September 17, 2021

What Radiologists Should Know About Normal Pressure Hydrocephalus.

RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
Till IlliesUwe Kehler
September 16, 2021

Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.

Brain : a Journal of Neurology
Agustina LegazAgustín Ibañez
September 16, 2021
Open Access

Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study.

Frontiers in Neurology
Jacy Bezerra ParmeraArtur Martins Coutinho
September 16, 2021
Open Access

Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome.

Frontiers in Molecular Neuroscience
Juan Francisco Vázquez-CostaTeresa Sevilla
September 16, 2021

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol.

BMJ Open
Rebecca M BollingerSusan L Stark
September 16, 2021

Data analysis with Shapley values for automatic subject selection in Alzheimer's disease data sets using interpretable machine learning.

Alzheimer's Research & Therapy
Louise BlochAlzheimer’s Disease Neuroimaging Initiative
September 16, 2021
Preprint
Open Access

Integrating Transcriptomics, Genomics, and Imaging in Alzheimer's Disease: A Federated Model

BioRxiv : the Preprint Server for Biology
J. WuYalin Wang
September 16, 2021
Review
Open Access

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.

Acta Pharmaceutica Sinica. B
Liang Han, Chen Jiang
September 16, 2021

Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease.

Neurobiology of Aging
Devashi PaliwalAlzheimer's Disease Neuroimaging Initiative
September 16, 2021

Changes in histaminergic system in neuropsychiatric disorders and the potential treatment consequences.

Current Neuropharmacology
Ling Shan, Dick F Swaab

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-neuroimaging/a5242adb-290c-4f90-bd45-b0d1bbfc9166